What do you need to know about the Merck pharmacy prescription drug program

The Merck Pharmacy Drug Program is a federal program that provides access to a variety of pharmaceuticals to Medicare and Medicaid beneficiaries. 

This program, which was launched in 2009, allows eligible patients to obtain prescription drugs for up to two full months at a time. 

The program is the most comprehensive prescription drug benefit program in the country. 

There are more than 10 million Medicare and Medicare Advantage enrollees, and it provides access for some 60 million individuals to over $100 billion in pharmaceuticals. 

In 2018, Medicare and the Centers for Medicare & Medicaid Services (CMS) estimated that about $6.7 billion in annual benefits were paid out to beneficiaries.

In 2019, the agency estimated that $1.4 billion in benefits were transferred to beneficiaries through the program. 

While many beneficiaries qualify for Medicare, there are some who do not, and the program is intended to help people who are eligible for other federal programs. 

Some of the most common reasons for not being able to obtain a prescription from the Merk Pharmacy Program are health issues such as a high blood pressure or heart condition, or other medical conditions. 

Merck is a global pharma company with headquarters in New York City.

The company is widely recognized for its pharmaceuticals, medical devices and other medical products, including its cancer drugs, including Celebrex, Cetuximab, and Zyprexa.